Description: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments. The company's in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. It also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. The company markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Home Page: www.dexcom.com
DXCM Technical Analysis
6340 Sequence Drive
San Diego,
CA
92121
United States
Phone:
858 200 0200
Officers
| Name | Title |
|---|---|
| Mr. Kevin Ronald Sayer | Exec. Chairman, CEO & Pres |
| Mr. Jereme M. Sylvain | Exec. VP, CFO & Chief Accounting Officer |
| Mr. Jacob Steven Leach | Exec. VP & COO |
| Mr. Paul R. Flynn | Exec. VP of Global Revenue |
| Mr. Sean Christensen | Director of Corp. Affairs & Head of Investor Relations |
| Mr. Michael Brown | Exec. VP & Chief Legal Officer |
| Mr. Matthew Dolan | Exec. VP of Strategy, Corp. Devel. & Dexcom Labs |
| Ms. Sadie M. Stern | Exec. VP & Chief HR Officer |
| Mr. Andrew K. Balo | Exec. VP of Global Medical Affairs, Access & Evidence |
| Mr. Steven R. Pacelli | Exec. VP & MD of Dexcom Ventures |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 120.4819 |
|---|---|
| Trailing PE: | 239.2609 |
| Price-to-Book MRQ: | 24.6553 |
| Price-to-Sales TTM: | 16.5357 |
| IPO Date: | 2005-04-14 |
| Fiscal Year End: | December |
| Full Time Employees: | 6300 |